申请人:Grunenberg Alfons
公开号:US20110152266A1
公开(公告)日:2011-06-23
The present invention relates to a novel cocrystal compound of 5-chloro-N-((5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide (rivaroxaban) and malonic acid, to processes for its preparation, to medicaments comprising this compound and to their use for controlling diseases.
本发明涉及一种5-氯-N-((5S)-2-氧代-3-(4-(3-氧代-4-吗啉基)苯基)-1,3-噁唑啉-5-基甲基)-2-噻吩羧酰胺(利伐沙班)和丙二酸的新型共晶化合物,其制备方法,包含该化合物的药物以及它们用于控制疾病的用途。